文献
J-GLOBAL ID:201702285798060158
整理番号:17A1546867
経口ハロペリドールあるいはオランザピン摂取は高脂肪食により妨害されるカンナビノイド受容体レベルの異なるおよび領域特異的増加を誘発する【Powered by NICT】
Oral haloperidol or olanzapine intake produces distinct and region-specific increase in cannabinoid receptor levels that is prevented by high fat diet
著者 (5件):
Delis Foteini
(Department of Pharmacology, Medical School, University of Ioannina, 45110, Ioannina, Greece)
,
Rosko Lauren
(Georgetown University Medical Center, Georgetown University, Washington, DC, 20007, USA)
,
Shroff Aditya
(Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, 14203, USA)
,
Leonard Kenneth E.
(Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, 14203, USA)
,
Thanos Panayotis K.
(Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, 14203, USA)
資料名:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
(Progress in Neuro-Psychopharmacology & Biological Psychiatry)
巻:
79
号:
PB
ページ:
268-280
発行年:
2017年
JST資料番号:
T0252A
ISSN:
0278-5846
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)